Search research articles
Contact Us
Filters
Showing results (181-190 of 250) with videos related to
Page
of 25
Sort By:
Cancer Medicine
|
December 14, 2022
Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)
Min-Hee Ryu, Kyung Hee Lee, Lin Shen, et al.
Hepatology (Baltimore, Md.)
|
March 31, 2023
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers
Changhoon Yoo, Milind M Javle, Helena Verdaguer Mata, et al.
Lancet (London, England)
|
April 19, 2023
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, et al.
Oncotarget
|
June 1, 2017
Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen
Changhoon Yoo, Jihoon Kang, Kyu-Pyo Kim, et al.
Frontiers in Oncology
|
August 29, 2022
Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials
Matthew Ledenko, Samuel O Antwi, Shiho Arima, et al.
Targeted Oncology
|
March 19, 2021
Correction to: Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis
Yeonghak Bang, Changhoon Yoo, Sara Lonardi, et al.
Clinical Lung Cancer
|
May 23, 2015
Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection
Changhoon Yoo, Shinkyo Yoon, Dae Ho Lee, et al.
Cancer Research and Treatment
|
September 4, 2020
Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer
Hyung-Don Kim, Jwa Hoon Kim, Yeon-Mi Ryu, et al.
Journal of Hepatology
|
March 28, 2025
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study
Changhoon Yoo, Makoto Ueno, Heinz-Josef Klümpen, et al.
Nature Medicine
|
February 20, 2024
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 250) with videos related to
Sort By:
Page
of 25
Cancer Medicine
|
December 14, 2022
Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)
Min-Hee Ryu, Kyung Hee Lee, Lin Shen, et al.
Hepatology (Baltimore, Md.)
|
March 31, 2023
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers
Changhoon Yoo, Milind M Javle, Helena Verdaguer Mata, et al.
Lancet (London, England)
|
April 19, 2023
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, et al.
Oncotarget
|
June 1, 2017
Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen
Changhoon Yoo, Jihoon Kang, Kyu-Pyo Kim, et al.
Frontiers in Oncology
|
August 29, 2022
Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials
Matthew Ledenko, Samuel O Antwi, Shiho Arima, et al.
Targeted Oncology
|
March 19, 2021
Correction to: Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis
Yeonghak Bang, Changhoon Yoo, Sara Lonardi, et al.
Clinical Lung Cancer
|
May 23, 2015
Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection
Changhoon Yoo, Shinkyo Yoon, Dae Ho Lee, et al.
Cancer Research and Treatment
|
September 4, 2020
Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer
Hyung-Don Kim, Jwa Hoon Kim, Yeon-Mi Ryu, et al.
Journal of Hepatology
|
March 28, 2025
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study
Changhoon Yoo, Makoto Ueno, Heinz-Josef Klümpen, et al.
Nature Medicine
|
February 20, 2024
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, et al.
Page
of 25